What is NCT04512345 on ClinicalTrials.gov?
NCT04512345 is a ClinicalTrials.gov identifier for a specific clinical study; searching ClinicalTrials.gov for that exact NCT number is the fastest way to see the study’s official details (title, condition, study type, sites, enrollment, sponsor, and current status). The same NCT page also lists planned dates, eligibility criteria, and links to posted results if available.
Why does this NCT entry mention haloperidol decanoate?
When an NCT record is tied to “haloperidol decanoate,” it typically means the study uses the long-acting injectable (LAI) antipsychotic formulation as an intervention (often for people with schizophrenia or related psychotic disorders, depending on the protocol). The NCT page should specify:
- which arm(s) receive haloperidol decanoate
- dosing schedule (e.g., loading/maintenance approach)
- how outcomes are measured (symptom scales, relapse rates, safety endpoints)
What does the study aim to test?
ClinicalTrials.gov records for drug trials using haloperidol decanoate usually focus on one or more of the following, depending on the protocol:
- safety and tolerability of the regimen
- effectiveness for symptom control or relapse prevention
- comparison versus another treatment or placebo
- pharmacokinetic/pharmacodynamic outcomes (less common, but happens)
The NCT page is where you can confirm the exact study objectives and primary/secondary endpoints.
What’s the status of NCT04512345 (recruiting, completed, results posted)?
The NCT listing shows the study’s current “Recruiting/Not yet recruiting/Active, not recruiting/Completed/Terminated” status and key dates. It also indicates whether results have been posted on ClinicalTrials.gov (separate from journal publications).
If you want, I can pull the exact details—what should I look for?
Share the ClinicalTrials.gov URL (or the trial title/condition shown on the NCT04512345 page), and I can extract and summarize the key items you care about—such as:
- the condition studied
- inclusion/exclusion criteria
- haloperidol decanoate dosing and schedule
- endpoints and visit timeline
- trial sponsor and trial phase
DrugPatentWatch angle (patent/exclusivity checks)
If you’re also trying to connect the trial to commercial development (e.g., a specific version/formulation or brand), DrugPatentWatch.com can help find related patent and exclusivity information for haloperidol decanoate products. Use it to check whether any patents or regulatory exclusivities are still active, and how that might relate to trial timing. DrugPatentWatch link
Sources
- [1] https://clinicaltrials.gov/ (search for NCT04512345)
- [2] https://www.drugpatentwatch.com/